Verona Pharma (NASDAQ:VRNA) Coverage Initiated at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $80.00 price target on the stock. Cantor Fitzgerald’s price target points to a potential upside of 29.01% from the company’s previous close. VRNA […]
Cantor Fitzgerald initiated coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $80.00 price target on the stock. Cantor Fitzgerald’s price target points to a potential upside of 29.01% from the company’s previous close. VRNA […]